🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Reported risk: The product contains methylchloroisothiazolinone (MCI). Dermal contact with MCI-containing products can provoke allergic contact dermatitis to sensitised persons. The cream also contains isobutylparaben, as indicated in the list of ingredients on the packaging. This paraben has a potential endocrine disrupting activity. The product does not comply with the Cosmetic Products Regulation.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Distributor
Category of measure
Ban on the marketing of the product and any accompanying measures
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.